Verona Pharma Share Discussion Threads

[joeblogg2] 13/1/2020 07:49

Company transforming news and great for copd suffers!!

[diversification] 13/1/2020 07:47

With such low float they has the potential to go to 2/3/4 a years over the course of this week.

[mo7800] 13/1/2020 07:39

£2.00 by close?

[basem1] 13/1/2020 07:37

350m sufferers worldwide I am also in CiR which has the sales already and is just starting its recovery after a large stock overhangEvery man and his dog is after a stake at CIR at present

[diversification] 13/1/2020 07:37

92p across the pond in after hours trade Friday. That was before this news. Massive anticipation has grown over the weekend in the US where they normally dictate terms.

[ak62] 13/1/2020 07:03

Happy days

[mo7800] 13/1/2020 06:44

Phase 3 can be anything upto 3000 patients. Verona phase 2b trial was 412 patients. This next step will be a huge cost. Massive funding or go with another partner. Another partner would be the ideal option.

[basem1] 13/1/2020 06:36

Bet the 45000 sell trade on Friday is feeling just a bit sick now ?

[shearluc] 13/1/2020 06:19

100m COPD suffers in Chinahttps://www.sciencedaily.com/releases/2018/04/180409185331.htm

[aimshares] 13/1/2020 06:11

This will be the top rising share today This is going to rocket .Well done to the long term holders I no many have been here for many many years . Great results :)

[mo7800] 13/1/2020 06:06

Over 15 million in the US.

[mo7800] 13/1/2020 05:36

These data bring clarity to planning the design, including dose selection, endpoints and background therapy, of our Phase 3 program. We look forward to discussing these new and compelling data, together with the positive results from our previous clinical studies, in an End-of-Phase 2 meeting with the FDA planned for 2Q 2020. We are committed to demonstrating ensifentrine's potential to produce sustained bronchodilation and anti-inflammatory effects in symptomatic COPD patients in Phase 3 trials, which we expect to start in 3Q 2020." Big Pharma will buy this out before it gets to 3Q

[mo7800] 13/1/2020 05:24

It's been a long wait for LTH

[aimshares] 13/1/2020 05:12

Fantastic results met all end points https://www.investegate.co.uk/verona-pharma-plc--vrp-/gnw/verona-pharma-reports-positive-top-line-data-in-4-week-phase-2b-copd-study-with-nebulized-ensifentrine-on-top-of-tiotropium-therapy/20200113050010H9493/

[diversification] 13/1/2020 05:10

Those results are as good as it gets. Very impressive.

[haveapunt1] 11/1/2020 15:55

Hopefully your right basem1.

Just couldn’t see the point or need for the RNS at 11pm on a Friday.

Just release the data 7am on Monday as every other stock does

No point giving an RNS to say your issuing an RNS. Wasn’t price sensitive

Either way, there appears no leak given the slow volume and low trading amounts last week and on Friday

Or was this a ploy for the Nasdaq to hike to the price after hours. Hope a few trading after hours don’t get caught with their pants down Monday

[basem1] 11/1/2020 15:37

Always right with after hours trading I should have finished by saying

[basem1] 11/1/2020 15:36

You got me thinking about the need for a conference call if the results were good. I looked back to the last good news reported which was 26 March 2018 and they did a CC that day too. They seem to do one whether the news is good or bad. I'm erring on the side of good news, why put that RNS out last night if it was going to be bad and also the after hours price reaction. I've watched enough CNBC and Bloomberg to know the market is almost nearly always right.

[haveapunt1] 11/1/2020 15:11

Look at the trades after hours, peanuts, PI money likely buying in with FOMO

[basem1] 11/1/2020 15:09

The rise in after hours trading ? Someone knows something Could be wrong but the market action doesn't lie

[ak62] 11/1/2020 15:08

It is very strange thing to do

Why issue rns to say we are issuing
An update on result on Monday ??

Don’t make sense
Any highlights much appreciated

[haveapunt1] 11/1/2020 15:01

Basem1. What does that tell us? No disrespect intended but LSE ramp everything.

The 11pm RNS has no relevance imo to good or bad news. I still see no reason to issue it

Just release 7am Monday and within the RNS stage investor call at 2pm

Very odd, even more so with an RNS at 11pm.

Fingers crossed it’s postive for us all but please don’t let LSE posters wear rose tinted, few of us caught with motif and still feeling the pain

Never know an investor call for phase 2 results, ever. Normally just issued.